CRT-D Therapy in Heart Failure: How Much Do NYHA Class IV Patients Benefit?
dc.contributor.author | Lehmann, Michael E. | en_US |
dc.contributor.author | Aaronson, Keith D. | en_US |
dc.date.accessioned | 2010-06-01T18:27:06Z | |
dc.date.available | 2010-06-01T18:27:06Z | |
dc.date.issued | 2006-05 | en_US |
dc.identifier.citation | LEHMANN, MICHAEL H.; AARONSON, KEITH D. (2006). "CRT-D Therapy in Heart Failure: How Much Do NYHA Class IV Patients Benefit?." Journal of Cardiovascular Electrophysiology 17(5): 491-494. <http://hdl.handle.net/2027.42/71659> | en_US |
dc.identifier.issn | 1045-3873 | en_US |
dc.identifier.issn | 1540-8167 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/71659 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16684020&dopt=citation | en_US |
dc.format.extent | 126136 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Inc | en_US |
dc.rights | 2006 by Futura Publishing Company, Inc. | en_US |
dc.title | CRT-D Therapy in Heart Failure: How Much Do NYHA Class IV Patients Benefit? | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbsecondlevel | Physiology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | * Department of Internal Medicine/Division of Cardiovascular Disease, University of Michigan School of Medicine, Ann Arbor, Michigan, USA | en_US |
dc.identifier.pmid | 16684020 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/71659/1/j.1540-8167.2006.00478.x.pdf | |
dc.identifier.doi | 10.1111/j.1540-8167.2006.00478.x | en_US |
dc.identifier.source | Journal of Cardiovascular Electrophysiology | en_US |
dc.identifier.citedreference | 1. DEFIBRILAT Study Group: Actuarial risk of sudden death while awaiting cardiac transplantation in patients with atherosclerotic heart disease. Am J Cardiol 1991; 68: 545 - 546. | en_US |
dc.identifier.citedreference | 2. MERIT-HF Study Group: Effect of Metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 1999; 353: 2001 - 2007. | en_US |
dc.identifier.citedreference | 3. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576 - 1583. | en_US |
dc.identifier.citedreference | Moss AJ, Hall J, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilbe r D, Brown MW, Heo M, for the Multicenter Automatic Defibrillator Implantation Trial Investigators: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 326: 1933 - 1940. | en_US |
dc.identifier.citedreference | Curtis AB, Cannom DS, Bigger T, DiMarco JP, Estes NAM, Steinman RC, Parides MK: Baseline characteristics of patients in the coronary artery bypass graft (CABG) patch trial. Am Heart J 1997; 133: 787 - 798. | en_US |
dc.identifier.citedreference | Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G, for the Multicenter Unsustained Tachycardia Trail Investigators: A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999; 341: 1882 - 1890. | en_US |
dc.identifier.citedreference | Moss AJ, Zareba W, Hall J, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, for the Multicenter Automatic Defibrillator Implantation Trial II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877 - 883. | en_US |
dc.identifier.citedreference | Kadish A, Dyer A, Daubert JP, Quigg R, Estes M, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH, for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators: Prophylactic defibrillator implantation in patients with non-ischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151 - 2158. | en_US |
dc.identifier.citedreference | Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LK, Fraulo ES, Fishbein DP, Luceri RM, Ip HJ, for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225 - 237. | en_US |
dc.identifier.citedreference | Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Messenger J, for the MIRACLE Study Group: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845 - 1853. | en_US |
dc.identifier.citedreference | Linde C, Leclercq C, Rex S, Garrigue S, Lavergne T, Cazeau S, McKenna W, Fitzgerald M, Deharo JC, Alonso C, Walker S, Braunschweig F, Bailleul C, Daubert JC, on behalf of the MUltisite STimulation In Cardiomyopathy (MUSTIC) Study Group: Long-term benefits of biventricular pacing in congestive heart failure: Results from the MUltisite STimulation In Cardiomyopathy (MUSTIC) Study. J Am Coll Cardiol 2002; 40: 111 - 118. | en_US |
dc.identifier.citedreference | Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K, for the Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators: Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD trial. JAMA 2003; 289: 2685 - 2694. | en_US |
dc.identifier.citedreference | Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, Boehmer JP, Higginbotham MB, De Marco T, Foster E, Yong PG: Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular tachyarrhythmias. J Am Coll Cardiol 2003; 42: 1454 - 1459. | en_US |
dc.identifier.citedreference | Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM, for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators: Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140 - 2150. | en_US |
dc.identifier.citedreference | Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, for the Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators: The effect of cardiac resynchronization on morbidity in heart failure. N Engl J Med 2005; 352: 1539 - 1549. | en_US |
dc.identifier.citedreference | Desai AD, Burke MC, Hong TE, Kim S, Salem Y, Yong PG, Knight BP: Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2006; doi: | en_US |
dc.identifier.citedreference | Uretsky BF, Sheahan RG: Primary prevention of sudden cardiac death in heart failure: Will the solution be shocking? J Am Coll Cardiol 1997; 30: 1589 - 1597. | en_US |
dc.identifier.citedreference | Wathen MS, Degroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ, for the PainFREE Rx II Investigators: Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous implantable cardioverter-defibrillators: Pacing fast ventricular tachycardia reduces shock therapies (PainFREE Rx II) trial results. Circulation 2004; 110: 2591 - 2596. | en_US |
dc.identifier.citedreference | Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, Shalaby A, Schaechter A, Subacius H, Kadish A, for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators: Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 2006; 113: 776 - 782. | en_US |
dc.identifier.citedreference | Saxon LA, Wiener I, DeLurgio DB, Natterson PD, Laks H, Drinkwater DC, Stevenson WG: Implantable defibrillators for high-risk patients with heart failure who are awaiting cardiac transplantation. Am Heart J 1995; 130: 501 - 506. | en_US |
dc.identifier.citedreference | Saba S, Atiga WL, Barrington W, Ganz LI, Kormos RL, MacGowan GA, Mathier MA, McNamara DM, Obioha-Ngwu O, Murali S: Selected patients listed for cardiac transplantation may benefit from defibrillator implantation regardless of an established indication. J Heart Lung Transplant 2003; 22: 411 - 418. | en_US |
dc.identifier.citedreference | Sandner SE, Wieselthaler G, Zuckermann A, Taghavi S, Schmidinger H, Pacher R, Ploner M, Laufer G, Wolner E, Grimm M: Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation. Circulation 2001; 104 ( Suppl I ): I171 - I176. | en_US |
dc.identifier.citedreference | Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D, for the Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure: Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995; 333: 77 - 82. | en_US |
dc.identifier.citedreference | Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN, for the Department of Veterans Affairs Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure: QRS duration and mortality in patients with congestive heart failure. Am Heart J 2002; 143: 1085 - 1091. | en_US |
dc.identifier.citedreference | Lecoq G, Leclercq C, Leray E, Crocq C, Alonso C, de Place C, Mabo P, Daubert C: Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure. Eur Heart J 2005; 26: 1094 - 1100. | en_US |
dc.identifier.citedreference | Molhoek SG, Bax JJ, Bleeker GB, Holman ER, Van Erven L, Bootsma M, Boersma E, Steendijk P, Van Der Wall EE, Schalij MJ: Long-term follow-up of cardiac resynchronization therapy in patients with end-stage heart failure. J Cardiovasc Electrophysiol 2005; 16: 701 - 707. | en_US |
dc.identifier.citedreference | Higgins SL, Yong P, Scheck D, McDaniel M, Bollinger F, Vadecha M, Desai S, Meyer DB, for the Ventak CHF Investigators: Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000; 36: 824 - 827. | en_US |
dc.identifier.citedreference | Arya A, Haghjoo M, Dehghani MR, Alasti M, Alizadeh H, Kazemi B, Sadr-Ameli MA: Effect of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in patients with an implantable cardioverter-defibrillator. Heart Rhythm 2005; 2: 1094 - 1098. | en_US |
dc.identifier.citedreference | Bleeker GB, Schalij MJ, Molhoek SG, Verwey H, Holman ER, Boersma E, Steendijk P, Vander Wall EE, Bax JJ: Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. J Cardiovasc Electrophysiol 2004; 15: 544 - 549. | en_US |
dc.identifier.citedreference | Feldman AM, de Lissovoy G, Bristow MR, Saxon LA, De Marco T, Kass DA, Boehmer J, Singh S, Whellan DJ, Carson P, Boscoe A, Baker TM, Gunderman MR: Cost effectiveness of cardiac resynchronization therapy in the comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) trial. J Am Coll Cardiol 2005; 46: 2311 - 2321. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.